At first, immunohistochemical analysis of Ki67 revealed that the proliferation of 4T1 tumor cells was remarkably weakened by Mito‐FFa treatment (60 μg per mouse, Figure 6c,d). The gene discussed is MKI67; the disease is neoplasm.